ABSTRACTS

You are invited to submit informative abstracts of up to 500 words (2800 characters) which would not include the title of the abstract, author affiliations and other headings like Aims, Methods, Results & Conclusions. The abstract may include a maximum of two charts or figures as Supporting Data (which will not be included in 500 words / 2800 characters limit).

Abstracts must be submitted according to guidelines given below. All abstracts must be submitted using the Abstract Submission Form.

ABSTRACT TITLE

Please write the title in Title Case (each main word has a capital letter). Do not use quotation marks.

e.g. The Results of the Research Case Study and Its Participants

AUTHORS & AFFILIATIONS

• The full names (no initials) of all participating authors (including yourself) must be included on the abstract. Please do not include degrees or professional titles.

• Author Affiliations – please include the name of your organization, the city, the state and the country.

ABSTRACT TEXT

Abstracts that merely state the results that will be presented will be subject to rejection. All abstracts are subject to review by the Scientific Committee and acceptance into the program is not guaranteed. The Committee suggests that the abstract follow the format outlined below:

• Aims

• Methods

• Results

• Conclusions

CONFLICT OF INTEREST STATEMENT

If the research described in the abstract was supported by a commercial company, you must indicate the company’s role in analysing the data or preparing the abstract.

One of the following must appear at the bottom of the abstract:

“No conflict of interest to disclose”

“This research was supported by__________________. The company had no role in analysing the data or preparing the abstract.”

“This research was supported by__________________. The company inserts free text describing company role in data analysis or abstract preparation.”

This conflict-of-interest statement is mandatory for all abstracts submitted and will appear wherever the abstracts are published. For oral presentations, a sample slide will be available to presenters for disclosure of conflicts of interest to be displayed as the first or second slide of their presentation

ABSTRACT CATEGORIES

The abstracts must be submitted in one of the following categories:

• Acute Leukemia

• Lymphoma and Chronic Lymphocytic Leukemia

• Multiple Myeloma

• Myelodysplastic Syndromes

• Myeloproliferative Neoplasm

• Hemoglobinopathies, Primary Immune Deficiency, and Metabolic Disorders

• Conditioning Regimens

• Graft-versus-host Disease

• Infectious and Non-infectious complications

• Pediatric Transplantation

• Cell and Gene Therapy

• Quality of Life / Survivorship

• Basic Science

• Allied Health including Nursing, Pharmacology, and Laboratory Aspects

Submission of the abstract carries with it an obligation to present the accepted abstract in person or virtually without any change in scientific content during the allotted time in the above conference. Withdrawal of presentation should be intimated to the scientific committee on or before AUGUST 31, 2026 by writing to the conference Secretariat at secretariat@annualmeeting2026.apbmt.org.

If an author as the presenting author is not able to present the paper for the conference due to any reason, prior permission has to be obtained from the Program Committee regarding the change in the presenting author

POSTER PRESENTATION GUIDELINES

• Poster size & material: A0 (Portrait)​ paper

• Participants are kindly advised to bring their own posters, which will be displayed at the event.

• The poster must contain the name of all authors and the author’s Institution or University

Welcome Message

Dear Colleagues and Friends,

On behalf of the Organizing Committee, it is our privilege to invite you to the 31st Annual Congress of the Asia-Pacific Blood and Marrow Transplantation Group (APBMT), to be held in Manila, the Philippines, from 1st to 4th October 2026.

The APBMT continues to serve as a key forum for advancing the science and practice of hematopoietic stem cell transplantation and immune-effector cell therapy across the Asia Pacific region. The annual congress brings together clinicians, researchers, nurses, technologists, and allied professionals to share knowledge, exchange experiences, and strengthen collaborative efforts that enhance patient care and clinical outcomes.

The 2026 meeting will take place at SPACE at One Ayala, a state-of-the-art events venue located in the heart of Makati City, Metro Manila’s premier business and financial district. The vicinity around One Ayala offers a wide range of experiences for congress participants — from international restaurants and local cuisine to vibrant cafés and cultural attractions.

The congress program will include plenary lectures, symposia, oral and poster presentations, and working group sessions designed to highlight recent developments, address current challenges, and explore future directions in transplantation and cellular therapy.

We are pleased to invite your organization to participate in APBMT 2026 as a valued partner and sponsor. The meeting will offer an excellent opportunity to present your innovations, products, and technologies to an audience of international experts and practitioners. Your involvement will contribute to the continued advancement of our field and the growth of collaborative science in the region.

We look forward to welcoming you to Manila in 2026 for a productive, inspiring, and memorable congress.

Sincerely,

Prof. Alok Srivastava

President APBMT

Dr. Francisco Lopez

President PSBMT